These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1950032)

  • 1. [The effect of pH and amount of antacids on bile acid binding in a quasi-natural reflux milieu].
    Kurtz W; Güldütuna S; Leuschner U
    Z Gastroenterol; 1991 May; 29(5):237-41. PubMed ID: 1950032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bile acid binding by antacids in a "quasi-natural" reflux milieu].
    Kurtz W; Güldütuna S; Leuschner U
    Z Gastroenterol; 1989 Jul; 27(7):370-3. PubMed ID: 2773532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of bile acids in the development of peptic lesions. Studies on the bile acid-binding capacity of a new kind of antacid].
    Kurtz W
    Fortschr Med; 1991 Oct; 109(29):592-4. PubMed ID: 1783351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)].
    Baur C; Becker A; Linder R; Schwan T
    Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption of bile acids by sucralfate, antacids, and cholestyramine in vitro.
    Ståhlberg M; Jalovaara P; Laitinen S; Mokka R; Hentilä R; Järvensivu P; Kairaluoma M
    Clin Ther; 1987; 9(6):615-21. PubMed ID: 3440273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new antacid, almagate.
    Beneyto JE; Fábregas JL; Moragues J; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1350-4. PubMed ID: 6439224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bile acids, antacids, and cholestyramine on transmural electrical potential difference in man.
    Caspary WF; Kausch H
    Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):369-75. PubMed ID: 31754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
    Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
    Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding properties in vitro of antacids for conjugated bile acids.
    Clain JE; Malagelada JR; Chadwick VS; Hofmann AF
    Gastroenterology; 1977 Sep; 73(3):556-9. PubMed ID: 19335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.
    Sutphen JL; Dillard VL; Pipan ME
    Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative assessment of a new antacid formulation based on magaldrate.
    McCafferty DF; Woolfson AD
    J Clin Hosp Pharm; 1983 Dec; 8(4):349-55. PubMed ID: 6662972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antacids and bile salts.
    Kivilaakso E
    Scand J Gastroenterol Suppl; 1982; 75():16-9. PubMed ID: 6755652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
    Clark CK; Merritt AM; Burrow JA; Steible CK
    J Am Vet Med Assoc; 1996 May; 208(10):1687-91. PubMed ID: 8641951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antacids on salicylate kinetics.
    Shastri RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):480-4. PubMed ID: 4055159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antacid tablets and liquid in fasting and fed men and women.
    Thomson AB; Pinchbeck B; Kirdeikis J; Kirdeikis P; Zuk L; Brunet MK; Jurima-Romet M; Murray PE
    Clin Ther; 1988; 10(2):158-68. PubMed ID: 3273863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Binding of bile salts and lysolecithin by various antacids in biological media].
    Guthauser UJ; Häcki WH
    Schweiz Med Wochenschr; 1987 Feb; 117(9):322-7. PubMed ID: 3563454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of bile acids by hydrotalcite and other antacid preparations.
    Llewellyn AF; Tomkin GH; Murphy GM
    Pharm Acta Helv; 1977; 52(1-2):1-5. PubMed ID: 887639
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
    Hürlimann S; Michel K; Inauen W; Halter F
    Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.